Mereo BioPharma Group plc (MREO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q2'20 |
|---|
| Cash from Operations | -4.31M | -7.68M | -7.31M | -7.65M | -8.33M | -9.42M | -7.52M | -7.9M | -7.99M | -6.79M | 2.66M | -7.75M | -9.25M | -20.62M | -13.93M | -24.15M | -20.89M | 13.75M | -26M | -14.73M |
| Operating CF Margin % | - | - | - | -1530.2% | - | - | - | - | - | -678.9% | 498.47% | -86.16% | -259.48% | -2477.86% | -2064.15% | - | - | 54.53% | - | - |
| Operating CF Growth % | 48.23% | 18.45% | 2.79% | 3.2% | -4.23% | -38.75% | -382.78% | -1.93% | 13.59% | 67.07% | 119.08% | 67.9% | - | 1.31% | - | -275.62% | 19.66% | 193.34% | -14.44% | 59.98% |
| Net Income | -6.72M | -7.35M | -7.02M | -14.62M | -12.89M | -7.05M | -15M | -12.26M | -8.95M | -9.11M | -6.53M | -1.75M | -12.08M | -17.66M | -10.44M | -24.83M | 867.99K | 16.79M | -50.94M | -156.93M |
| Depreciation & Amortization | 171K | 722K | -11K | 298K | 270K | 274K | 282K | 257K | 275K | 281K | 282K | 271K | 227K | 362.86K | 201.58K | 541.82K | 520.52K | 361.07K | 758.64K | 1.28M |
| Stock-Based Compensation | 1.6M | 1.54M | 0 | 2.06M | 2.28M | 1.51M | 1.74M | 2.09M | 2.05M | 815K | 1.53M | 943K | 1.64M | 910.42K | 1.02M | 1.49M | 1.04M | 1.22M | 442.39K | 564.4K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.09M | 0 | -1.88M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.53M | -345.96K | -910K | 5.45M | 2.52M | -5.02M | 6.84M | 586K | 141K | 3.33M | -1.79M | -495K | 595K | -2.92M | -3.05M | -1.4M | -24.15M | 3.56M | 24.38M | 149.06M |
| Working Capital Changes | 2.16M | -2.25M | 636K | -843K | -514K | 857K | -1.38M | 1.42M | -1.51M | -2.1M | 9.17M | -6.72M | 371K | -58.72K | -1.67M | 2.2M | 1.39M | -3.91M | 435.89K | -4.89M |
| Change in Receivables | -94.84K | -476.47K | 0 | -744K | 952K | -576K | -226K | 0 | -477K | 688K | 1.69M | 0 | -499K | 387.08K | -184.41K | 429.05K | 1.52M | -2.33M | 880.49K | -696.38K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.96M | 450.35K | 0 | -1.95M | 362K | 843K | -1.06M | 0 | 127K | 987K | -756K | 0 | 812K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -300K | -1.52K | 300K | 0 | -320K | 0 | 0 | 1K | -700K | 0 | 0 | 0 | -419K | -97.67K | 450.84K | 1.04M | -575.03K | 692 | -208.34K | 2.1M |
| Capital Expenditures | -299.5K | -1.52K | 0 | 0 | -20K | 0 | 0 | 0 | -700K | 0 | 0 | 0 | -419K | 1.22K | -929 | -12.96K | -729K | 0 | -20.89K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 11.76% | 0.15% | 0.14% | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 355.03K | -817.26K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -503 | 0 | 300K | 0 | -300K | 0 | 0 | 1K | 0 | 0 | 0 | 0 | 0 | -98.89K | 451.77K | 1.05M | 153.98K | 692 | -96.7K | 2.47M |
| Cash from Financing | 0 | 38.73K | 0 | -134K | 422K | -40K | -594K | 46.78M | 0 | 0 | 7.91M | 67K | 0 | -542.14K | 262.69K | -378.5K | -2.52M | 108.33M | -13.99M | 63.13M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 38.73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | -134K | 422K | -40K | -594K | 46.78M | 0 | 0 | -796.05K | 67K | 0 | 275.91K | 262.69K | -177.72K | -240.71K | 108.33M | -13.99M | 63.13M |
| Net Change in Cash | -4.77M | -7.71M | -7.43M | -6.36M | -7.32M | -10.72M | -6.91M | 38.77M | -8.76M | -5.11M | 9.56M | -6.84M | -8.37M | -25.04M | -34.2M | -34.92M | -24.37M | 120.01M | -38.13M | 48.55M |
| Free Cash Flow | -4.31M | -7.68M | -7.31M | -7.65M | -8.65M | -9.42M | -7.52M | -7.9M | -8.69M | -6.79M | 2.66M | -7.75M | -9.67M | -20.61M | -13.93M | -24.17M | -21.62M | 13.75M | -26.02M | -14.73M |
| FCF Margin % | - | - | - | -1530.2% | - | - | - | - | - | -678.9% | 498.47% | -86.16% | -271.24% | -2477.71% | -2064.29% | - | - | 54.53% | - | - |
| FCF Growth % | 50.14% | 18.43% | 2.79% | 3.2% | 0.48% | -38.75% | -382.78% | -1.93% | 10.1% | 67.07% | 119.08% | 67.91% | - | 4.65% | - | -275.72% | 16.92% | 193.34% | -14.4% | 59.98% |
| FCF per Share | -0.03 | -0.05 | -0.05 | -0.05 | -0.06 | -0.06 | -0.05 | -0.06 | -0.06 | -0.05 | 0.02 | -0.06 | -0.08 | -0.17 | -0.11 | -0.21 | -0.19 | 0.13 | -0.39 | -0.63 |
| FCF Conversion (FCF/Net Income) | 0.64x | 1.05x | 1.04x | 0.52x | 0.65x | 1.35x | 0.50x | 0.64x | 0.89x | 0.75x | -0.41x | 4.43x | 1.68x | 1.17x | 1.49x | 0.97x | -24.07x | 1.64x | 0.97x | 0.19x |
| Interest Paid | 0 | 0 | 0 | 7K | 7K | 11K | 0 | 6K | 4K | 0 | 4K | 183K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |